Clinical Manual of Child and Adolescent Psychopharmacology 3rd Edition at Meripustak

Clinical Manual of Child and Adolescent Psychopharmacology 3rd Edition

Books from same Author: Robert L Findling and Molly Mcvoy

Books from same Publisher: American Psychiatric Association Publishing

Related Category: Author List / Publisher List


  • Price: ₹ 5978.00/- [ 17.00% off ]

    Seller Price: ₹ 4962.00

Sold By: Store4Doctors      Click for Bulk Order

Offer 1: Get 17.00 % + Flat ₹ 75 discount on shopping of ₹ 500 [Use Code: MPSTK75]

Offer 2: Get 17.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 17.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Robert L Findling and Molly Mcvoy
    PublisherAmerican Psychiatric Association Publishing
    Edition3rd Edition
    ISBN9781615370443
    Pages545
    BindingPaperback
    LanguageEnglish
    Publish YearApril 2017

    Description

    American Psychiatric Association Publishing Clinical Manual of Child and Adolescent Psychopharmacology 3rd Edition by Robert L Findling and Molly Mcvoy

    The new, third edition of the Clinical Manual of Child and Adolescent Psychopharmacology has been thoroughly revised, yet its mission remains the same: to keep clinicians up-to-date on the latest research so that they can provide state-of-the-art care to their young patients. To this end, the book describes and explores those elements that are specific to pediatric psychopharmacology; this defines and positions the volume at the nexus of child and adolescent psychiatry, pediatrics, and pharmacology. A stellar roster of contributors addresses new treatments for youths with disruptive behavior disorders, mood disorders, anxiety disorders, pervasive developmental disorders, and psychotic illnesses and tackles some of the most important emerging issues in the field. For example, advances in understanding the long-term treatment effects of medications in pediatric populations are thoroughly reviewed, including not only maintenance studies that consider the durability of efficacy but also clinical trials of greater duration designed to specifically evaluate long-term safety. In addition, recent studies of combination therapies are examined, helping clinicians better understand how to treat the complicated patients that arrive every day at a prescribing clinician's office.